"Cysteine Endopeptidases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
| Descriptor ID |
D003546
|
| MeSH Number(s) |
D08.811.277.656.262.500 D08.811.277.656.300.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cysteine Endopeptidases".
Below are MeSH descriptors whose meaning is more specific than "Cysteine Endopeptidases".
This graph shows the total number of publications written about "Cysteine Endopeptidases" by people in this website by year, and whether "Cysteine Endopeptidases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 4 | 5 |
| 1999 | 0 | 2 | 2 |
| 2000 | 2 | 3 | 5 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 3 | 3 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 4 | 6 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cysteine Endopeptidases" by people in Profiles.
-
McAleer MA, Jakasa I, Raj N, O'Donnell CPF, Lane ME, Rawlings AV, Voegeli R, McLean WHI, Kezic S, Irvine AD. Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis. Br J Dermatol. 2018 08; 179(2):431-441.
-
Ammayappan A, Upadhyay C, Gelb J, Vakharia VN. Complete genomic sequence analysis of infectious bronchitis virus Ark DPI strain and its evolution by recombination. Virol J. 2008 Dec 22; 5:157.
-
Cailhier JF, Sirois I, Laplante P, Lepage S, Raymond MA, Brassard N, Prat A, Iozzo RV, Pshezhetsky AV, H?bert MJ. Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem. 2008 Oct 03; 283(40):27220-9.
-
Napper A. Biochemical-Based Assays for HTS --CHI's 14th Annual Conference. IDrugs. 2008 Jul; 11(7):493-6.
-
Monnerie H, Le Roux PD. Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: the role of cysteine proteases. Exp Neurol. 2008 Sep; 213(1):145-53.
-
Myers MC, Shah PP, Beavers MP, Napper AD, Diamond SL, Smith AB, Huryn DM. Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype. Bioorg Med Chem Lett. 2008 Jun 15; 18(12):3646-51.
-
Shah PP, Myers MC, Beavers MP, Purvis JE, Jing H, Grieser HJ, Sharlow ER, Napper AD, Huryn DM, Cooperman BS, Smith AB, Diamond SL. Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L. Mol Pharmacol. 2008 Jul; 74(1):34-41.
-
Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, Weiss SR. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol. 2006 Jun; 80(12):5768-76.
-
Argyris EG, Pomerantz RJ. HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host. Trends Microbiol. 2004 Apr; 12(4):145-8.
-
Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, Stephanopoulos G, Stephanopoulos G, Brown RH, Gullans SR. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics. 2004 Jan 15; 16(2):229-39.